Pathogenic variants in BRCA1/2 are also associated with ovarian cancer risk [76, 77], as are pathogenic variants in PALB2 [78], RAD51C [79, 80], and RAD51D [80, 81]. This evidence concerns the gene BRCA1 and ovarian cancer.